Library of Resources
- Berg References
- Chappell References
- Disis References
- Ellis References
- Buyse M_Biomarkers and Surrogate end points.pdf
- Eisenhauer EA_New response evaluation criteria in solid tumours.pdf
- Neumayer L, Design and conduct issues in surgical clinical trials.pdf
- Peppercorn J_Ethics of Mandatory Research.pdf
- Schilsky RL_Personalized Medicine in Oncology the future is now.pdf
- Sydes MR_Potential pitfalls in the design and reporting of clinical trials.pdf
- Fong References
- Garrett-Mayer References
- Gonen References
- McShane LM_Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK).pdf
- Ransohoff DF_Rules of evidence for cancer molecular-marker discovery and validation.pdf
- Ratain MJ_Testing the Wrong Hypothesis in Phase II Oncology Trials.pdf
- Rubinstein LV_Design Issues of Randomized Phase II Trials.pdf
- Vickers AJ_Setting the bar in phase II trials.pdf
- Hayes References
- Karp References
- Krailo References
- LoRusso References
- Marcucci References
- Morrison References
- Normolle References
- Rademaker References
- Regan References
- Schwartz References
- Shyr References
- Sood References
- Suman References
- Taghian References
- Thomas References
- Chou TC_Quantitative Analysis of Dose-Effect Relationships.pdf
- Iwasa T_Inhibition of Insulin-Like Growth Factor.pdf
- Marks LB_Guest Editor's Introduction to Quantec.pdf
- Moretti L_AT-101 PanBcl2 Inhibitor.pdf
- Normolle D_Designing Dose-Escalation Trials.pdf
- Ocana A_Synergy made simple.doc
- Pijls-Johannesma M_A systematic methodology review of phase I radiation dose escalation trials.pdf
- Tallarida RJ_An Overview of Drug Combination Analysis with Isobolograms.pdf
- ThrptcRatioTCP Sigmoidal curves_PDF.pdf
- Villalona References
- Von Roenn References
- Wahl References
- Weinberg References
- Weiss References